Viewing Study NCT00454194


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2025-12-28 @ 12:15 AM
Study NCT ID: NCT00454194
Status: COMPLETED
Last Update Posted: 2017-03-21
First Post: 2007-03-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization: